To include your compound in the COVID-19 Resource Center, submit it here.
Melinta Therapeutics Inc. (New Haven, Conn.) has found a path to becoming public by acquiring a majority stake of fellow infectious company Cempra Inc. (NASDAQ:CEMP). The combined
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury